Pfizer steps up race for weight-loss drug
STORY: Pfizer said on Monday (June 26) it is scrapping the development of obesity and diabetes drug lotiglipron to focus on other treatments.
That as the drugmaker races to develop a rival to weight loss drugs from Danish company Novo Nordisk, which have seen soaring demand.
Pfizer said it chose to discontinue the drug after results showed elevated levels of liver enzymes in patients during clinical studies.
It will now focus on its other weight loss drug, danuglipron.
Latest trials show it helped Type 2 diabetes patients lose weight on par with rivals in a mid-stage study.
Pfizer said it would finalize plans for the late-stage trial of danuglipron by the end of 2023.
Drugmakers have been racing to target the weight loss market, which is estimated to reach $100 billion by the end of the decade.
And Novo Nordisk is already testing a high-dose oral version of semaglutide, the drug behind brands Ozempic and Wegovy.
Late-stage trials found that the obesity pill helped patients lose 15% of their body weight.
The company has struggled to keep up with huge demand for Ozempic and Wegovy, which are sold as a once-weekly injection.
It plans to seek approval for the pill version later this year and said the market launch is yet to be determined.
- 累了...美式漢堡餐廳頂讓 老闆掛紅布條酸"奧客"民視影音110,189 次觀看・12 小時前
- 唐綺陽本週星座運勢解析：02/26 - 03/03 2024Voyage TV1,378 次觀看・18 小時前
- 彰化風鈴木大道亂象多 民眾「擺拍」趴路中騎士氣炸華視影音10,377 次觀看・14 小時前
- 歌神上海巡演"未開口聲先出" 張學友秒變臉暫停民視影音4,022 次觀看・16 小時前
- Toyz暈慘了！認追求篠崎泫「養妳一輩子」霸氣喊5位數包養費娛樂星聞1,902 次觀看・10 小時前
- 鍾明軒傳達中國"很安全" 鄭家純網路怒槓民視影音1,876 次觀看・9 小時前
- 挑戰「一日北高」出師不利？ 柯跌倒波及黃珊珊華視影音233,271 次觀看・1 天前
- 入選2023米其林指南的炒鱔魚！在城堡裡喝下午茶買伴手禮！媲美鼎泰豐的人氣小籠湯包！台南東區精選五家人氣美食！我是馬鈴薯小姐雁靈369 次觀看・19 小時前
- 熊本遊客、商務客大增 飯店貼公告「小黃供不應求」｜#鏡新聞鏡新聞828 次觀看・19 小時前
- 一分鐘報天氣/週一(02/26) 今冷氣團再增強 週三四短暫回溫空檔Yahoo奇摩新聞（報氣象）2,805 次觀看・16 小時前